Viral Delivery of an Epitope from Haemophilus influenzae Induces Central Nervous System Autoimmune Disease by Molecular Mimicry [PDF]
J. Ludovic Croxford +2 more
openalex +1 more source
ABSTRACT Objective The Gold Coast criteria permit diagnosis of amyotrophic lateral sclerosis (ALS) even without upper motor neuron (UMN) signs. However, whether ALS patients with UMN signs (ALSwUMN) and those without (ALSwoUMN) share similar characteristics and prognoses remains unclear.
Hee‐Jae Jung +7 more
wiley +1 more source
Glucose measurement in cerebrospinal fluid compared to peripheral blood in dogs with central nervous system disease. [PDF]
Wolfe M, Schlein L, Henry J, McGrath S.
europepmc +1 more source
Murine Models of Central Nervous System Disease following Congenital Human Cytomegalovirus Infections. [PDF]
Moulden J +4 more
europepmc +1 more source
Advances in the Application of Susceptibility-Weighted Imaging (SWI) in Central Nervous System Diseases [PDF]
栩毅 全
openalex +1 more source
PS4:76 The challenge of central nervous system small vessel disease in autoimmunity: a case report [PDF]
Leila Duarte +6 more
openalex +1 more source
Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia
ABSTRACT Objective To determine the test performance of cutaneous phosphorylated alpha‐synuclein (P‐SYN) in dementia with Lewy bodies (DLB), individuals with reduced Montreal Cognitive Assessment (MoCA) and healthy controls. Methods This is the first subgroup analysis of the Synuclein‐One study, a prospective, blinded study evaluating P‐SYN detection ...
Christopher H. Gibbons +31 more
wiley +1 more source
Infectious and immune-mediated central nervous system disease in 48 COVID-19 patients. [PDF]
Finsterer J, Scorza FA.
europepmc +1 more source
Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley +1 more source

